טוען...
Coexistent Breast Cancer and Essential Thrombocythemia: How We Addressed the Therapeutic Challenges
Essential thrombocythemia (ET) occurring with breast cancer is uncommon; the therapeutic approach varies and poses a challenge. A 65-year-old female presented to us after being diagnosed with hormone positive, HER2-negative infiltrating ductal carcinoma. She had a platelet count of 600 thou/cu mm. H...
שמור ב:
| הוצא לאור ב: | Case Rep Hematol |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Hindawi
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6109582/ https://ncbi.nlm.nih.gov/pubmed/30159181 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/2080185 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|